Parallel Advisors’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.92K | Hold |
618
| – | – | ﹤0.01% | 2859 |
|
|
2025
Q4 | $5.56K | Hold |
618
| – | – | ﹤0.01% | 2812 |
|
|
2025
Q3 | $10.7K | Hold |
618
| – | – | ﹤0.01% | 2511 |
|
|
2025
Q2 | $5.8K | Buy |
618
+380
| +160% | +$3.12K | ﹤0.01% | 2685 |
|
|
2025
Q1 | $1.69K | Sell |
238
-85
| -26% | -$859 | ﹤0.01% | 3022 |
|
|
2024
Q4 | $3.77K | Buy |
323
+317
| +5,283% | +$4.95K | ﹤0.01% | 2741 |
|
|
2024
Q3 | $123 | Sell |
6
-33
| -85% | -$761 | ﹤0.01% | 3329 |
|
|
2024
Q2 | $873 | Sell |
39
-36
| -48% | -$857 | ﹤0.01% | 2994 |
|
|
2024
Q1 | $2.06K | Sell |
75
-192
| -72% | -$5.33K | ﹤0.01% | 2819 |
|
|
2023
Q4 | $8.14K | Sell |
267
-22
| -8% | -$632 | ﹤0.01% | 2364 |
|
|
2023
Q3 | $9.14K | Buy |
289
+50
| +21% | +$1.94K | ﹤0.01% | 2246 |
|
|
2023
Q2 | $9.75K | Sell |
239
-49
| -17% | -$1.99K | ﹤0.01% | 2178 |
|
|
2023
Q1 | $10.7K | Buy |
288
+114
| +66% | +$4.47K | ﹤0.01% | 2097 |
|
|
2022
Q4 | $6.07K | Sell |
174
-4
| -2% | -$190 | ﹤0.01% | 2246 |
|
|
2022
Q3 | $10K | Buy |
178
+1
| +0.6% | +$62 | ﹤0.01% | 2001 |
|
|
2022
Q2 | $9K | Sell |
177
-23
| -12% | -$1.17K | ﹤0.01% | 2041 |
|
|
2022
Q1 | $14K | Buy |
200
+1
| +0.5% | +$85 | ﹤0.01% | 1869 |
|
|
2021
Q4 | $24K | Sell |
199
-66
| -25% | -$8.27K | ﹤0.01% | 1696 |
|
|
2021
Q3 | $36K | Buy |
265
+141
| +114% | +$21.3K | ﹤0.01% | 1436 |
|
|
2021
Q2 | $20K | Sell |
124
-26
| -17% | -$2.02K | ﹤0.01% | 1687 |
|
|
2021
Q1 | $12K | Buy |
150
+115
| +329% | +$7.72K | ﹤0.01% | 1848 |
|
|
2020
Q4 | $2K | Buy |
+35
| New | +$1.27K | ﹤0.01% | 2331 |
|
|
2017
Q4 | – | Sell |
-1,000
| Closed | -$20K | – | 2120 |
|
|
2017
Q3 | $20K | Buy |
+1,000
| New | +$18.8K | ﹤0.01% | 1007 |
|
Other funds holding NTLA
AIM
VPM
VCM
RP
